RecruitingNot ApplicableNCT05462561

Vascularized Composite Bladder Allograft Transplantation

Robotic Vascularized Composite Bladder Allograft Transplantation: A Phase 0 (First-in-Human), Single Institutional Study for Deceased-Donor Bladder Transplantation

Sponsor

University of Southern California

Enrollment

5 participants

Start Date

May 1, 2023

Study Type

INTERVENTIONAL

Conditions

Bladder Dysfunction Neurogenic Bladder Immunosuppression

Summary

This phase 0 trial tests the feasibility, functionality, and sustainability of vascularized composite bladder allograft transplantation in treating patients with terminal bladder pathology. A vascularized bladder allograft transplantation may provide a more durable and better-tolerated alternative to standard urinary diversion, which employs bowel. A robotic surgical approach will be employed.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Quality-of-Life Assessment and a procedure called Robotic Vascularized Composite Bladder Allograft Transplantation for people with bladder dysfunction, immunosuppression, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.